Cargando…
Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer’s Disease
The clinical diagnosis and treatment of Alzheimer’s disease (AD) represent a challenge to clinicians due to the variability of clinical symptomatology as well as the unavailability of reliable diagnostic tests. In this study, the development of a novel electrochemical assay and its potential to dete...
Autores principales: | Garyfallou, Goulielmos-Zois, Ketebu, Orlando, Şahin, Samet, Mukaetova-Ladinska, Elizabeta B., Catt, Michael, Yu, Eileen Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713623/ https://www.ncbi.nlm.nih.gov/pubmed/29077013 http://dx.doi.org/10.3390/s17112464 |
Ejemplares similares
-
Informal Caregiving and Alzheimer’s Disease: The Psychological Effect
por: Hellis, Emily, et al.
Publicado: (2022) -
Current and Future Perspectives of Liaison Psychiatry Services: Relevance for Older People’s Care
por: Mukaetova-Ladinska, Elizabeta B.
Publicado: (2016) -
Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010) -
Tubulin Isotypes and Posttranslational Modifications in Vascular Dementia and Alzheimer’s Disease
por: Santiago-Mujika, Estibaliz, et al.
Publicado: (2022) -
A Clinical Update on Delirium: From Early Recognition to Effective Management
por: Cerejeira, Joaquim, et al.
Publicado: (2011)